US Patent Issued to Shenzhen Salubris Pharmaceuticals on Oct. 28 for "Treatment method using a complex of angiotensin II receptor antagonist metabolite and NEP inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,719, issued on Oct. 28, was assigned to Shenzhen Salubris Pharmaceuticals Co. Ltd. (Guangdong, China).

"Treatment method using a complex of angiotensin II receptor antagonist metabolite and NEP inhibitor" was invented by Jingchao Sun (Guangdong, China), Sirao Yang (Guangdong, China), Lei Li (Guangdong, China), Yue Yang (Guangdong, China), Xuege Shen (Guangdong, China), Wei Lin (Guangdong, China), Shiying He (Guangdong, China) and Ji Chen (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application belongs to the technical field of drug application, relates to a treatment method using a complex of an angiotensin II recepto...